The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was $4.51 for the day, up 4.16% from the previous closing price of $4.33. In other words, the price has increased by $4.16 from its previous closing price. On the day, 2.23 million shares were traded. IRWD stock price reached its highest trading level at $4.68 during the session, while it also had its lowest trading level at $4.24.
Ratios:
Our analysis of IRWD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.07. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 09, 2024, initiated with a Market Perform rating and assigned the stock a target price of $5.
On August 08, 2024, CapitalOne Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $4.
On January 17, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $21.Craig Hallum initiated its Buy rating on January 17, 2024, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 27 ’24 when Davis Andrew bought 60,434 shares for $4.00 per share.
Davis Andrew sold 5,360 shares of IRWD for $21,869 on Nov 18 ’24. The SVP, Chief Business Officer now owns 284,685 shares after completing the transaction at $4.08 per share. On Nov 18 ’24, another insider, Emany Sravan Kumar, who serves as the SVP, COO and CFO of the company, sold 11,001 shares for $4.08 each. As a result, the insider received 44,884 and left with 309,572 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRWD now has a Market Capitalization of 721726336 and an Enterprise Value of 1248388992. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.99. Its current Enterprise Value per Revenue stands at 3.299 whereas that against EBITDA is 12.817.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $15.70, while it has fallen to a 52-week low of $3.06. The 50-Day Moving Average of the stock is 12.44%, while the 200-Day Moving Average is calculated to be -19.40%.
Shares Statistics:
IRWD traded an average of 1.75M shares per day over the past three months and 2913330 shares per day over the past ten days. A total of 160.02M shares are outstanding, with a floating share count of 155.77M. Insiders hold about 2.66% of the company’s shares, while institutions hold 103.18% stake in the company. Shares short for IRWD as of 1734048000 were 12084477 with a Short Ratio of 6.90, compared to 1731628800 on 8567112. Therefore, it implies a Short% of Shares Outstanding of 12084477 and a Short% of Float of 14.6.
